{
  "name" : "_cyber.sci-hub.se_MTAuMjE0Ny9pam4uczEyNzM0OQ==_huang2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Current applications and future prospects of nanomaterials in tumor therapy",
    "authors" : [ "Yu Huang", "Chao-Qiang Fan", "Hui Dong", "Su-Min wang", "Xiao-Chao Yang", "Shi-Ming Yang" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "© 2017 Huang et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you\nhereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).\nInternational Journal of Nanomedicine 2017:12 1815–1825\nsubmit your manuscript | www.dovepress.com Dovepress 1815\nhttp://dx.doi.org/10.2147/IJN.S127349\nYu Huang1\nChao-Qiang Fan1\nHui Dong1\nSu-Min wang1\nXiao-Chao Yang2\nShi-Ming Yang1\n1Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, People’s Republic of China; 2Department of Biomedical Materials Science, School of Biomedical engineering, Third Military Medical University, Chongqing, People’s Republic of China\nchemotherapy, surgery, and a combination of these treatments, tumors are still the foremost\nkiller worldwide among human diseases, due to their specific limitations, such as multidrug\nresistance and side effects. Therefore, it is urgent and necessary to develop new strategies for\ntumor therapy. Recently, the fast development of nanoscience has paved the way for designing\nnew strategies to treat tumors. Nanomaterials have shown great potential in tumor therapy, due\nto their unique properties, including passive targeting, hyperthermia effects, and tumor-specific\ninhibition. This review summarizes the recent progress using the innate antitumor properties of\nmetallic and nonmetallic nanomaterials to treat tumors, and related challenges and prospects\nare discussed.\nKeywords: tumor, nanomaterials, nanoparticles, nanotechnology\nIntroduction The development of tumors occurs at the molecular level1 when multiple subgroups\nof genes undergo genetic alterations. Either tumor-suppressor genes are inactivated\nor oncogenes are activated, which leads to malignant proliferation of tumor cells,\ntissue infiltration, and organ dysfunction.2 Many methods have been developed for\ntumor therapy, such as immunotherapy,3,4 gene therapy,5,6 and radiofrequency ablation\n(RFA).7–9 Nevertheless, traditional radiotherapy,10,11 surgery,12–14 and especially\nchemotherapy15,16 are still the major strategies utilized in clinical tumor treatments.\nHowever, chemotherapy has a number of problems, including nonspecific distribution\nof the drug and the lack of tumor-specific treatments.17 In the continuous fight against\ntumors, patients have to be administered drugs that increase in dose over time, which\nis associated with considerable adverse effects, such as multidrug resistance and\naccumulative systemic toxicity. Chemotherapy also causes side effects in healthy\ntissues, which have negative impacts on the quality of life of the patients.18,19 In addi-\ntion, chemotherapy may concomitantly damage adjacent organs or tissues, and these\nadverse effects are difficult to avoid.20,21\nIn recent decades, the development of nanotechnology has provided an opportunity\nto overcome the aforementioned side effects. The integration of various nanomaterials\n(NMs) with spectroscopic, biochemical, and optical methods has allowed the\ndevelopment of advanced methods for tumor therapy, which may revolutionize the\ntreatment of tumors. An emerging approach is to utilize nanotechnology and NMs\nto minimize toxicity to healthy tissues. Various NMs have performed attractively in\nvarious aspects of antitumor treatment and garnered intense research interest, and\nCorrespondence: Shi-Ming Yang Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Xinqiao Street, Shapingba, Chongqing 400037, People’s Republic of China Tel +86 023 6875 5604 email shimingyang@yahoo.com\nXiao-Chao Yang Department of Biomedical Materials Science, School of Biomedical engineering, Third Military Medical University, Number 30, Gaotanyan Street, Shapingba, Chongqing 400038, People’s Republic of China Tel +86 023 6877 2482 email xcyang@tmmu.edu.cn\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\n1816"
    }, {
      "heading" : "Huang et al",
      "text" : "they have presented great potential for antitumor treatment\nby enhancing the effectiveness of treatments and reducing\nsystemic side effects.\nThe term “nano-” is derived from the Greek noun nanos,22\nand a nanometer (nm) is equivalent to 10-9 m.23 The specific\nphysical and/or chemical properties of NMs make them\nvery attractive in biomedical applications.24,25 Over the past\nfew decades, the explosion of studies involving NMs can be\nascribed to their special optical, thermodynamic, magnetic,\nand mechanical properties.26–28 Potential medical applications\nof NMs have been recognized to have good biocompatibility.29\nNanoparticles (NPs) with suitable diameter range have been\nreported to be able to enter blood circulation and undergo\nendocytosis into cells.30 Furthermore, scientific research\nshows that NM-based therapeutics have great potential in the\ntreatment of tumors, diabetes, infection, neurodegenerative\ndisease, and inflammation.31–33 The integration of tumor ther-\napy with NMs is expected to bring about new breakthroughs\nfor nanotechnology in the field of medicine.\nThe physical and chemical properties of NMs impact on\nbiodistribution, cellular processes, and cytotoxic effects.27,34,35\nFor example, the size of the NM affects cellular tropism by\nfacilitating or inhibiting actin polymerization.36 In addition\nto size, the shape of NMs influences organ and cellular\ntropism.37 Spherical NMs promote phagocytosis of mac-\nrophages, but disk-shaped structures do not. By tailoring\nthese aspects, specific properties of NMs can be used to\ndesign new biomedical applications, which include various\nclinical and research activities and modulation of processes\nin target cells.38 With the development of nanotechnology,\nthe integration of NMs into tumor therapeutics is one of the\nrapidly advancing fields, and more new NMs will be increas-\ningly used in the field of tumor treatment.\nBased on nanotechnology, various NMs have been devel-\noped, such as iron oxide NPs, gold NPs (AuNPs), cerium oxide\nNPs, carbon-based materials, polymeric NPs, and quantum\ndots (QDs).39–44 NMs have shown great potential in tumor\nprevention, detection, diagnosis, imaging, and treatment. Due\nto their specific physical, chemical, and biological properties\nand unique structure, NMs are able to work at the molecular\nlevel. Therefore, NMs themselves are antigenic or medici-\nnally active, and can stimulate a strong immune response\nin the body.45 Some NMs can kill or inhibit pathogenic cell\ntypes by exploiting their autoimmunity or cellular toxicity\n(selective block by toxicity).46–48 Various NMs themselves are\nused as potential antitumor drugs, and are being developed\nas photothermal therapy (PTT) agents.49,50 Therefore, this\nreview discusses some specific metallic NMs (MNMs) and\nnonmetallic NMs that act as a medicine or drug additive in\ntumor therapy (Figure 1)."
    }, {
      "heading" : "Metallic NMs",
      "text" : "MNMs are metal or metal oxide nanocrystals. MNMs are\nreadily prepared, have surfaces relatively easy to modify,\nand in general have low toxicity.51,52 Because of their unique\nproperties, the advantage of using MNMs lies primarily in\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n1817\nNanomaterials in tumor therapy\ntheir ability to interact directly with cell membranes and\nintracellular structures.41,42 As discussed earlier, these special\nproperties make MNMs useful for numerous diagnostic and\ntherapeutic applications.53 Most MNMs for tumor therapy\nconsist of iron oxide, gold NPs, and cerium oxide NPs\n(Figure 2).54–57"
    }, {
      "heading" : "Iron oxide",
      "text" : "Iron oxide is a type of magnetic material that is used in tumor\nPTT and targeted therapy. PTT is based on using optical heat-\ning to facilitate direct and specific destruction of tumor cells.58\nPTT is a highly promising approach to tumor therapy. Photo-\ntherapy employs near-infrared light (NIR)-absorbing agents\nwith high absorption in the NIR region, which then release\nvibrational energy (heat) to kill the targeted tumor cells.\nFe 3 O 4 -based magnetic NPs are recognized as promising hyperthermia-specific agents. To treat metastatic bone\ntumors, Matsumine et al59 used novel Fe 3 O 4 powder for hyperthermia-induced apoptosis in several patients. One\nweek later, after incorporating Fe 3 O 4 in the adhesive that repaired the bone, patients were subjected to a localized\nelectromagnetic field at a temperature estimated to be\n40°C–45°C, in order to improve the lesion. This treatment stopped further metastatic progression, and demonstrated the\nbenefit of using iron oxide in bone-tumor treatments.\nIn addition to PTT, potential medical applications of\nmagnetic NPs have also been approved, due to their good\nbiocompatibility.26 According to a recent report, magnetic\nNPs with diameters ranging between several (~9 nm) and hundreds (~200 nm) of nanometers can circulate in blood\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n1818"
    }, {
      "heading" : "Huang et al",
      "text" : "vessels and undergo endocytosis into cells.60 The authors\nalso found that dimercaptosuccinic acid-coated iron oxide\nNPs have excellent potential for applications that target\nbreast-tumor cells.\nFurthermore, Fe 3 O 4 NPs can be functionalized using antibodies and achieve active targeted tumor therapy. There is a\nreport of using anti-HER2-conjugated polypyrrole-Fe 3 O 4 NPs to target and damage SK-BR-3 breast tumor cells in vitro.61\nIn fact, superparamagnetic iron oxide NPs (SPIONs; Fe 3 O 4 or Fe 2 O 3 )62 have been recognized for clinical use in the form of ferucarbotran (carboxydextran SPIONs), ferumoxides (dextran\nSPIONs), and ferumoxtran 10 (dextran SPIONs).63 These\nSPIONs are highly biodegradable and biocompatible; the iron\ncore is recycled into soluble ferritin iron or hemosiderin.64\nIron oxide NPs are also intensively used in imaging system\nas contrast agents in pathophysiological studies.65"
    }, {
      "heading" : "Gold NMs",
      "text" : "In recent years, AuNMs have shown important potential\nin various biomedical and research applications, such as\ncatalysis, bioanalysis, and imaging.66,67 The preparation\ntechnology is simple, and it is easy to control the size and\nshape of AuNMs.68,69 It has been reported that AuNMs can\nselectively and specifically recognize tumor cells.70,71 Studies\nreported in the literature have shown that AuNMs are eas-\nily functionalized, increase the time of circulation, and are\nstable in systemic circulation. In addition, AuNMs have low\ntoxicity and protect drugs from potential transformation in\ntissues and organs. Perhaps the most important property of\nAuNMs is their ability to destroy tumor cells.72 Thus, such\nAuNMs as AuNPs73,74 and gold nanocages56 are a promising\ntool for selectively killing tumor cells through photothermal\n(PT) damage.\nAuNPs can enhance the apoptotic effect of tumors,7\nwhich makes it possible to decrease radiation doses, thereby\nreducing side effects on surrounding normal tissues. AuNPs\ncan also enhance the effect of radiotherapy, which has been\nverified in vivo and in vitro in animal models of tumors.72\nAuNPs are commonly used as nanobioconjugates.69,70,73 The\nfunctionalization of NPs (eg, with polyethylene glycol [PEG]\nor antibodies) allows the nanobioconjugates to remain in the\nbloodstream and preferentially accumulate in tumor tissue.\nThese nanobioconjugates have the ability to penetrate the cell\nnucleus, increasing the likelihood that the active cytostatic\nsubstance acts directly on DNA.74 Studies reported in the\nliterature have shown that multifunctional AuNPs can be\nused both to image and treat tumors.70\nRFA is a novel therapeutic method for the treatment of\ntumors. This method uses imaging guidance to place a needle\nelectrode either through the skin or directly (during surgery)\ninto the pathological tissue. High-frequency electrical cur-\nrents pass through the electrode and create heat that destroys\ntumor cells. AuNPs have been used in this field, making it\npossible to destroy tumor cells noninvasively by RFA.12–14\nThe optical properties of nanoshells can be utilized in tumor-\nablation techniques with NIR light or RFA. Laroui et al\ndeveloped nanoshells coated with gold, absorbing specific\nwavelengths of light.75 Fortina et al synthesized nanoshells\nlinked to a ligand.76 Citrate-coated gold has been shown to\nhave antitumor properties.77,78\nXia et al56 synthesized novel gold nanocages ~45 nm in edge length. These gold nanocages have shown potential for\ntargeted PT inhibition of tumor cells. The nanocages were\ndesigned to convert 810 nm NIR light to heat via a large\nabsorptive cross section of 3.48×10-14 cm2, and strongly absorbed light in the NIR region. PT studies of the nanocages\nshowed that the PT cell-damage power-density threshold\nwas 1.5 W/cm2, which is lower than that of gold nanoshells\n(35 W/cm2) and gold nanorods (10 W/cm2). By conjugating\nthe nanocages with monoclonal antibodies (anti-HER2),\nthe nanocages can target epidermal growth factor receptors\n(EGFRs) that are overexpressed on the surface of breast-\ntumor cells. These results indicated that shape- and size-\nmodulated AuNMs could be potential tumor PTT reagents."
    }, {
      "heading" : "Cerium oxide nanoparticles",
      "text" : "Cerium oxide NPs include a cerium core surrounded by an\noxygen lattice.79 In normal cells, these NPs have an antioxidant\nand cytoprotective role under neutral pH. In an acid medium,\nwhich is one of the characteristics of tumor cells, these NPs\nshow prooxidant and cytotoxic effects. Pei et al studied the\nantitumor effects of cerium oxide NPs in in vitro models,\nand the results showed that cerium oxide NPs inhibited\nthe growth of tumor cells.80 There has been another report\nindicating that a high concentration (10 μg/mL) of cerium oxide NPs can suppress tumor-cell migration and inhibit\ntumor-cell proliferation.81"
    }, {
      "heading" : "Quantum dots",
      "text" : "Another popular type of NM are QDs.40 QDs are very small\nnanocrystals that emit fluorescence when stimulated by a spe-\ncific wavelength of light, and their diameter is approximately\n2–10 nm.44,82,83 Their structure consists of an inorganic core\nand shell, which can be modified with biological molecules,\nsuch as PEG.84 Their emission and absorption properties can\nbe controlled precisely by modulating their size and shape.85\nThe benefit of QDs for tumor therapy is attributed to their\nmechanisms of photosensitization and radiosensitization.\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n1819\nNanomaterials in tumor therapy\nWith electronic energy levels in the 1–5 keV range, QDs\ncan be used as photosensitizers for photodynamic treat-\nments, which have become an approved therapy modality\nfor some types of tumors. Because of their high electron\nand atom density, QDs act as radiosensitizers that absorb\nhigh-energy photons and cause localized or targeted damage\nto tumor cells.86"
    }, {
      "heading" : "Nonmetallic NMs",
      "text" : "There are several different types of nonmetal NMs (Figure 3),\nand carbon compounds are some of the most extensively\nstudied. Several different “pure” carbon-based constructs\nhave been studied, such as fullerenes and their derivatives,\nwhich are composed of carbon atoms arranged in a spherical\nshape called a truncated icosahedron, and carbon nanotubes\n(CNTs), which are most frequently studied in biological\nsystems.3,87 Fullerenes and their derivatives are readily acces-\nsible to cells, and are conjugated with various therapeutic mol-\necules because they have a unique nanostructure. In addition,\nthe pure carbon composition of fullerenes gives them good\nbiocompatibility. Moreover, carbon NMs have been linked\nwith biological molecules and polymers, and so can be effec-\ntively used for antitumor applications in vivo.40 Therefore,\nfunctional fullerenes and their derivatives can be linked to\na wide variety of active molecules to target tumor cells.87,88\nBased on these experiments, fullerenes and their derivatives\nhave become a new class of promising candidates for tumor\ntreatments. This portion of the review attempts to provide\ninsight into the progress of the use of fullerenes and their\nderivatives as tumor-therapy drugs."
    }, {
      "heading" : "C60",
      "text" : "C\n60 (or “bucky-ball” C 60 ) is a hollow sphere with a diameter\nof 1 nm, and is made up of 60 carbon atoms. C 60 is effective in terms of interactions with the immune system, and has\ndramatic potential as an antitumor drug. Compared with\nconventional antitumor chemicals, fullerenes and their\nderivatives are more efficient at inhibiting the growth of\ntumors. The result is not due to toxic effects on tumor cells,\nbut the fullerenes, which have almost no toxicity in vivo or\nin vitro, have a strong ability to enhance immunity and protect\nnormal tissues from tumor invasion.89,90\nEndohedral metallofullerenes (fullerenes encapsulating\na metal atom) have shown dramatic potential for biomedi-\ncal applications. For example, Hirahara et al91 synthesized\na multihydroxylated fullerene – Gd@C 82 (OH) 22 . Compared with some other clinical antitumor drugs, C 60 (OH) 20 and Gd@C 82 (OH) 22 NPs are highly effective at suppressing tumor growth in mice with negligible side effects. The high\nantitumor activity may be because the water-soluble NMs\ncan effectively trigger the host immune system to eliminate\ntumor cells and regulate the angiogenesis and oxidative\ndefense system in vivo.92"
    }, {
      "heading" : "Carbon nanotubes",
      "text" : "CNTs are coaxial graphite layers with cylinders.93 CNTs\nare formed by polymerization of single carbon atoms under\nspecific conditions.94 According to their structure, CNTs\ncan be divided into two categories: single-walled CNTs\n(SWCNTs) and multiwalled CNTs (MWCNTs). The former\nis a single cylindrical carbon wall, and the latter is an MW\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n1820"
    }, {
      "heading" : "Huang et al",
      "text" : "cylinder nested in other cylinders.95 With the development\nof nanotechnology, integration of CNTs into tumor thera-\npeutics is a rapidly advancing field.96,97 There are reports that\nCNTs promote the phagocytosis of dendritic cells at tumor\nsites, which produce more antigens to dendritic cells, sig-\nnificantly increasing the immunogenicity of proteins in the\ntumor.98 Similarly, inhaled CNTs can inhibit lung-resident\ndendritic cells and promote lung immune suppression.47\nRegarding the direct therapeutic effect, CNTs can induce\ntumor-tissue destruction by PTT, based on strong optical\nabsorbance under NIR-light excitation.99,100 Therefore, CNTs\nhave attracted interest as efficient PTT agents for tumor\ntreatments.101–103 Hyperthermia therapy is another type of\noptional solution for tumor treatment, especially for some\nsolid malignant tumors, such as breast and liver tumors.\nCNTs are also used as PT tumor-ablation mediators.100 Due\nto the thermal conductivity and optical properties of CNTs,\nthey have become mediators to optically stimulate NTs that\nare placed inside living cells and that kill tumor cells via\nlocal hyperthermia.\nThere has been much research to show the feasibility\nof CNTs in the treatment of malignant tumors. SWCNTs\nare promising candidates as a PTT agent, because they also\nhave high absorption in the NIR spectrum, which is ideal\nfor inducing PT damage to tumor cells or tissues. Continuous\nNIR radiation can lead to cell death, because of excessive\nlocal heating of SWCNTs. Kam et al104 showed that this\napproach is effective. In a similar work,105 the authors\nshowed that HER2-IGFR-SWCNTs were able to destroy all\ntargeted tumor cells. MWCNTs also efficiently absorb NIR\nlight and efficiently convert the absorbed energy into thermal\nenergy. MWCNTs can be stimulated with NIR irradiation\nto damage cervical tumor HeLa cells106 and EAC cells.107\nCNTs make it possible to damage tumor cells noninvasively,\nand the potential applications for CNTs in tumor therapy\nhave attracted much clinical interest. Therefore, CNTs can\nbe considered another class of tumor PTT system, and are\nhighly promising for clinical trials."
    }, {
      "heading" : "Graphene",
      "text" : "Graphene is an emerging NM with single-layered carbon\natoms in a two-dimensional honeycomb structure. Graphene\nhas attracted great interest since its tremendous ground-\nbreaking discovery in 2004.108–110 Graphene and its different\nsubtypes, such as graphene oxide (GO) and reduced graphene\noxide (RGO), have been extensively studied in the realm of\nnanomedicine, due to their exceptional physical, chemical,\nand mechanical properties.111 Graphene-based NMs have a\nwell-described role in tumor management.112 Graphene-based\nNMs are used mainly for PTT.\nYang et al113 reported that PEGylated GO (GO-PEG)\nshowed highly efficient tumor ablation under NIR-light\nirradiation, and GO-PEG was used for in vivo PTT. These\nauthors noticed that GO-PEG had no obvious side effects,\nand was safe during the treatment. In a follow-up study,\nYang et al114 verified that PEGylated nano-RGO (nRGO-PEG)\nwith an ultrasmall average diameter of ~27 nm was a better NM than GO for PTT with low-power laser irradiation. The\nin vivo PTT study demonstrated that nRGO-PEG was more\nefficient in tumor ablation and that NIR laser-power density\nwas greatly reduced. These results indicated that nRGO-\nPEG strongly absorbs light in the NIR region (808 nm),\nwith an intensity threshold of 0.15 W/cm2, to induce thermal\ndestruction of tumor cells. There have been some studies that\nreported that nanoparticles such as AuNPs,115,116 AgNPs,117\ncopper monosulfide NPs,118 and copper(I) oxide NPs119\nattached to the surface of GO synergistically enhanced PTT.\nThese results highlight that both the size and surface chem-\nistry of GO are critical to the effectiveness of in vivo PTT,\nwhich indicates that optimized nanographene could be a PTT\nreagent for treating tumors."
    }, {
      "heading" : "Chitosan nanoparticles",
      "text" : "Chitosan is a type of cationic oligosaccharide that is the\nmajor component of the exoskeleton of crustaceans and\ninsects.120 Chitosan is a biopolymer containing β-(1,4)2-amino-d-glucose and β-(1,4)-2-acetamido-d-glucose units.73 Chitosan NPs (ChNPs) are obtained by deacetyla-\ntion, which removes an acetate moiety from chitin. ChNPs\nare primarily degraded in the colon by the action of lysozyme\nand bacterial enzymes, and are finally eliminated in the\nfeces. Chitosan is a natural polysaccharide that has excellent\nbiocompatibility, biosecurity, biodegradability, and nontoxic\ncharacteristics.121,122 ChNPs are commonly modified with\nepichlorohydrin and PEG dicarboxylic acid.123,124 ChNPs\nalso have dramatic potential for tumor therapy.\nChNPs can directly affect the metabolism of tumor cells\nby inducing apoptosis and inhibiting cellular growth. Like-\nwise, ChNPs play a role in increasing the immune function\nof the organism by facilitating the contact between the drug\nand the tumor-cell membrane.125,126 Reports show that ChNPs\nhave high stimulatory activity on B and T lymphocytes and\nthe humoral immune system, which can be activated at the\nsame time.127 ChNPs also have a strong immunostimulating\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\n1821\nNanomaterials in tumor therapy\neffect by increasing the activation and accumulation of\npolymorphonuclear and macrophage cells, and they induce\ncytokine production after intravenous injection.128,129 There\nis another example that indicates that ChNPs have their own\nantitumor effects. ChNPs themselves have a positive charge;\ntherefore, they can neutralize the negative charges on the\nsurface of tumor cells, which has a tendency to contribute\nto their selective uptake. In this way, ChNPs can effectively\ninhibit proliferation of tumor cells by increasing the con-\ncentration of cytostatic agents at the tumor sites.130 All these\nattributes and examples show that ChNPs have great potential\nin tumor therapy."
    }, {
      "heading" : "Challenges and future perspectives",
      "text" : "Over the last 20 years, NMs have come to play a significant\nrole in commercial development. Indeed, we might expect\nto produce many breakthroughs and new prospects for the\nworld economy from advances in nanotechnology. With\nthe potentially wide application of NMs in the future, NMs\nmay be extensively used in various fields, especially tumor\ntherapy. NMs can be used for clinical diagnosis and tumor\ntherapy, based on their size, biocompatibility, surface\nchemistry, relatively good stability, and adjustable toxicity\nin biological systems. It is highly expected that the applica-\ntion of NMs in tumor therapy will greatly improve current\nmethods of tumor-cell detection, tumor imaging, and tumor\ntherapy, while reducing toxicity compared to traditional\ntumor treatments.\nHowever, there are several challenges in the field, and\nthere are still controversies about the potential risk of anti-\ntumor therapies. The most pressing problems are potential\nchronic and acute toxic effects; the potential toxicity of NMs\ncannot be ignored in antitumor therapy.131 There have been\nreports on the toxicity of NMs. NMs may be attached to the\nsurface of biological membranes by adsorption or electrostatic\ninteractions, and they can cause damage to cells by producing\nreactive oxygen species, leading to protein denaturation, lipid\nperoxidation, DNA damage, and ultimately cell death.132–134\nFor instance, NPs and CNTs can damage the respiratory and\ncardiovascular systems,135,136 and they can enter the central\nnervous system through the blood–brain barrier, resulting in\na variety of nervous system diseases.137–139 In vitro studies\nhave shown that CNTs can induce cell apoptosis, decrease\ncell viability, and disrupt the cell cycle and inflammatory\nresponses.140–142 It has been confirmed that CNTs can damage\nlung tissue143 and that they are toxic to the immune system\nin mice.46 Besides, the blood incompatibility of CNTs also\nlimits their use in the clinic. Although many studies have\nshown that the functionalization of CNTs can improve their\nwater-solubility, proof of their biocompatibility and safety\nis currently insufficient. For example, Li et al144 reported that\nsugar-functionalized SWCNTs formed stable homogeneous\naqueous solutions, Barzegar et al145 reported that noncovalent\nfunctionalized SWCNTs could also improve the water solu-\nbility of SWCNTs, and Ali et al146 functionalized SWCNTs\nwith the TGAD enzyme to render SWCNTs soluble in a\nplethora of solvents. However, the biocompatibility of func-\ntionalized SWCNTs was not evaluated in these studies. When\nQDs are applied in the body, their toxicity cannot be ignored,\nbecause they may contain heavy metals. It is necessary to\ncarry out a detailed toxicity study to ensure safety prior to\nfurther applications in humans. Further research will not be\nconducive to the clinical application of NMs and industrial\nproduction unless the toxicity problem is resolved. In addi-\ntion, only a few types of materials have been approved by\nthe US Food and Drug Administration, and very few NMs\nhave been approved as antitumor agents to enter Phase III\nclinical trials or enter the market, which indicates that NMs\nneed to be understood more deeply before their potential\napplication in tumor therapy.\nTherefore, the long-term toxicity of NMs to living\nsystems needs to be intensively studied. There is an article\nthat analyzes the possible toxicological implications of NMs\nin nanomedicine. The authors believed that it is necessary\nto research the mechanisms of injury in cells due to NMs\nextensively before NMs can be used in tumor treatments.147\nDevelopment of tumor therapies is a multidisciplinary\nfield, and with more in-depth research on tumor biology,\ntumor immunology, molecular biology, and NMs, an ideal\ntherapy or NM will eventually be produced for the treatment\nof tumors. The conversion of nanotechnology to routine\nclinical practice will require a multidisciplinary approach\nguided by clinical, ethical, and social perceptions. In view of\nthe significant research results being dedicated to the field,\nit may be expected that humans will greatly benefit from\nnanotechnology and NMs in the very near future, especially\nin tumor therapy."
    }, {
      "heading" : "Acknowledgment",
      "text" : "This study was supported by the Chongqing Science &\nTechnology Commission of China (cstc2016shmszx0915)."
    }, {
      "heading" : "Disclosure",
      "text" : "The authors report no conflicts of interest in this work.\nInternational Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com Dovepress\nDovepress\n1822"
    }, {
      "heading" : "Huang et al",
      "text" : ""
    }, {
      "heading" : "Huang et al",
      "text" : "93. Shvedova AA, Kisin ER, Porter D, et al. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus? Pharmacol Ther. 2009;121(2):192–204. 94. Terrones M, Terrones H. The carbon nanocosmos: novel materials for the twenty-first century. Philos Trans A Math Phys Eng Sci. 2003; 361(1813):2789–2806. 95. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev. 2006;58(14):1460–1470. 96. Karmakar A, Iancu C, Bartos DM, et al. Raman spectroscopy as a detection and analysis tool for in vitro specific targeting of pancreatic cancer cells by EGF-conjugated, single-walled carbon nanotubes. J Appl Toxicol. 2012;32(5):365–375. 97. Mahmood M, Karmakar A, Fejleh A, et al. Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and antitumor drug. Nanomedicine (Lond). 2009;4(8):883–893. 98. Shen H, Ackerman AL, Cody V, et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology. 2006; 117(1):78–88. 99. Heath JR, Davis ME. Nanotechnology and cancer. Annu Rev Med. 2008;59:251–265. 100. O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209(2):171–176. 101. Mocan L, Ilie I, Tabaran FA, et al. Surface plasmon resonance-induced photoactivation of gold nanoparticles as mitochondria-targeted therapeutic agents for pancreatic cancer. Expert Opin Ther Targets. 2013; 17(12):1383–1393. 102. Mocan L, Tabaran FA, Mocan T, et al. Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubes. Int J Nanomedicine. 2011;6: 915–928. 103. Mocan T, Matea CT, Cojocaru I, et al. Photothermal treatment of human pancreatic cancer using PEGylated multi-walled carbon nanotubes induces apoptosis by triggering mitochondrial membrane depolarization mechanism. J Cancer. 2014;5(8):679–688. 104. Kam NW, O’Connell M, Wisdom JA, Dai HJ. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A. 2005; 102(33):11600–11605. 105. Shao N, Lu S, Wickstrom E, Panchapakesan B. Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes. Nanotechnology. 2007;18(31):315101. 106. Biris AS, Boldor D, Palmer J, et al. Nanophotothermolysis of multiple scattered cancer cells with carbon nanotubes guided by time-resolved infrared thermal imaging. J Biomed Opt. 2009;14(2):021007. 107. Burlaka A, Lukin S, Prylutska S, et al. Hyperthermic effect of multiwalled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies. Exp Oncol. 2010;32(1): 48–50. 108. Novoselov KS, Geim AK, Morozov SV, et al. Electric field effect in atomically thin carbon films. Science. 2004;306(5696):666–669. 109. Rao CN, Sood AK, Subrahmanyam KS, Govindaraj A. Graphene: the new two-dimensional nanomaterial. Angew Chem Int Ed Engl. 2009; 48(42):7752–7777. 110. Allen MJ, Tung VC, Kaner RB. Honeycomb carbon: a review of graphene. Chem Rev. 2010;110(1):132–145. 111. Yang K, Feng LZ, Shi XZ, Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev. 2013;42(2):530–547. 112. Yang K, Hu LL, Ma XX, et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater. 2012;24(14):1868–1872. 113. Yang K, Zhang SA, Zhang GX, Sun XM, Lee ST, Liu ZA. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010;10(9):3318–3323. 114. Yang K, Wan JM, Zhang S, Tian B, Zhang YJ, Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials. 2012;33(7):2206–2214. 115. Zedan AF, Moussa S, Terner J, Atkinson G, El-Shall MS. Ultrasmall gold nanoparticles anchored to graphene and enhanced photothermal effects by laser irradiation of gold nanostructures in graphene oxide solutions. ACS Nano. 2013;7(1):627–636. 116. Dembereldorj U, Choi SY, Ganbold EO, et al. Gold nanorod-assembled PEGylated graphene-oxide nanocomposites for photothermal cancer therapy. Photochem Photobiol. 2014;90(3):659–666. 117. Shi JJ, Wang L, Zhang J, et al. A tumor-targeting near-infrared lasertriggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging. Biomaterials. 2014; 35(22):5847–5861. 118. Bai J, Liu YW, Jiang XE. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy. Biomaterials. 2014;35(22):5805–5813. 119. Hou CY, Quan HC, Duan YR, Zhang QH, Wang HZ, Li YG. Facile synthesis of water-dispersible Cu 2 O nanocrystal-reduced graphene oxide hybrid as a promising cancer therapeutic agent. Nanoscale. 2013;5(3):1227–1232. 120. Friedhuber AM, Chandolu V, Manchun S, Donkor O, Sriamornsak P, Dass CR. Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis. J Pharm Pharmacol. 2015;67(1):68–77. 121. Shi SF, Jia JF, Guo XK, et al. Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells. Int J Nanomedicine. 2012; 7:5593–5602. 122. Upadhyaya L, Singh J, Agarwal V, Tewari RP. Biomedical applications of carboxymethyl chitosans. Carbohydr Polym. 2013;91(1): 452–466. 123. Bodnar M, Hartmann JF, Borbely J. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules. 2005;6(5): 2521–2527. 124. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed. 2007;18(3):241–268. 125. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev. 2010;62(1):59–82. 126. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. Emerging nanopharmaceuticals. Nanomedicine. 2008;4(4):273–282. 127. Seferian PG, Martinez ML. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine. 2000;19(6): 661–668. 128. Shibata Y, Foster LA, Metzger WJ, Myrvik QN. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of n-acetyl-d-glucosamine, in mice. Infect Immun. 1997;65(5): 1734–1741. 129. Calvo P, Remuñan-López C, VilaJato JL, Alonso MJ. Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997;14(10): 1431–1436. 130. Jeong YI, Jin SG, Kim IY, et al. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids Surf B Biointerfaces. 2010;79(1):149–155. 131. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol. 2009;4(10):627–633. 132. Zhang WX, Karn B. Nanoscale environmental science and technology: challenges and opportunities. Environ Sci Technol. 2005; 39(5):94A–95A. 133. Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med. 2006;6(6):651–663.\nInternational Journal of Nanomedicine\nPublish your work in this journal\nSubmit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal\nThe International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. This journal is indexed on PubMed Central, MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition, EMBase, Scopus and the Elsevier Bibliographic databases. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.\nInternational Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com Dovepress\nDovepress\nDovepress\n1825\nNanomaterials in tumor therapy\n134. Hoshino A, Hanada S, Yamamoto K. Toxicity of nanocrystal quantum dots: the relevance of surface modifications. Arch Toxicol. 2011; 85(7):707–720. 135. Proffitt F. Yellow light for nanotech. Science. 2004;305(5685): 762–765. 136. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77(1):126–134. 137. Service RF. Nanotechnology grows up. Science. 2004;304(5678): 1732–1734. 138. Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol. 2006;36(3):189–217. 139. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627. 140. Manna SK, Sarkar S, Barr J, et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-κB in human keratinocytes. Nano Lett. 2005;5(9):1676–1684. 141. Ravichandran P, Baluchamy S, Sadanandan B, et al. Multiwalled carbon nanotubes activate NF-κB and AP-1 signaling pathways to induce apoptosis in rat lung epithelial cells. Apoptosis. 2010;15(12): 1507–1516. 142. Cui DX, Tian FR, Ozkan CS, Wang M, Gao HJ. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett. 2005; 155(1):73–85. 143. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med. 2004;61(5):442–447. 144. Li H, Chen Q, Han BH. Sugar-functionalized triptycenes used for dispersion of single-walled carbon nanotubes in aqueous solution by supramolecular interaction. New J Chem. 2016;40(4):3300–3307. 145. Barzegar A, Mansouri A, Azamat J. Molecular dynamics simulation of non-covalent single-walled carbon nanotube functionalization with surfactant peptides. J Mol Graph Model. 2016;64:75–84. 146. Ali K, Mahmoud WE. Development of functionalized single walled carbon nanotubes based triacylglycerol acylhydrolases. Synth Met. 2013;175:52–55. 147. Firme CP 3rd, Bandaru PR. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine. 2010;6(2): 245–256."
    } ],
    "references" : [ {
      "title" : "Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target. Oncotarget",
      "author" : [ "A Steven", "B. Seliger" ],
      "venue" : null,
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2016
    }, {
      "title" : "Pancreatic cancer: pathogenesis, prevention and treatment",
      "author" : [ "FH Sarkar", "S Banerjee", "YW. Li" ],
      "venue" : "Toxicol Appl Pharm",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2007
    }, {
      "title" : "Immunotherapy and tumor microenvironment",
      "author" : [ "HD Tang", "J Qiao", "YX. Fu" ],
      "venue" : "Cancer Lett",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2016
    }, {
      "title" : "Landscape of tumor-infiltrating T cell repertoire of human cancers",
      "author" : [ "B Li", "TW Li", "JC Pignon" ],
      "venue" : "Nat Genet",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2016
    }, {
      "title" : "Adenoassociated virus-mediated cancer gene therapy: current status",
      "author" : [ "JF Luo", "YX Luo", "JH Sun", "YR Zhou", "YJ Zhang", "X. Yang" ],
      "venue" : "Cancer Lett. 2015;356(2):347–356",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2015
    }, {
      "title" : "Neural stem cell-based gene therapy for brain tumors",
      "author" : [ "Kim SU" ],
      "venue" : "Stem Cell Rev Rep",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2011
    }, {
      "title" : "Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: current status",
      "author" : [ "LM Chen", "JH Sun", "XM. Yang" ],
      "venue" : "Cancer Lett",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2016
    }, {
      "title" : "Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation",
      "author" : [ "S Iwahashi", "M Shimada", "T Utsunomiya" ],
      "venue" : "Cancer Lett. 2016;375(1):47–50",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2016
    }, {
      "title" : "Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells",
      "author" : [ "CJ Gannon", "CR Patra", "R Bhattacharya", "P Mukherjee", "SA. Curley" ],
      "venue" : "J Nanobiotechnology",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2008
    }, {
      "title" : "Targeting the heat shock response in combination with radiotherapy: sensitizing cancer cells to irradiationinduced cell death and heating up their immunogenicity",
      "author" : [ "K Lauber", "N Brix", "A Ernst" ],
      "venue" : "Cancer Lett. 2015;368(2):209–229",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2015
    }, {
      "title" : "Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: a mono-institutional experience",
      "author" : [ "A Favarett", "G Pasello", "L Loreggian" ],
      "venue" : "Lung Cancer",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2010
    }, {
      "title" : "A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patientderived glioma cancer stem cells",
      "author" : [ "N Jhaveri", "F Agasse", "D Armstrong" ],
      "venue" : "Cancer Lett. 2016;371(2):240–250",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2016
    }, {
      "title" : "Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients",
      "author" : [ "SS Bernardes", "FP de Souza-Neto", "LN Ramalho" ],
      "venue" : "Cancer Lett. 2015;361(1):226–232",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2015
    }, {
      "title" : "Near-infrared optical guided surgery of highly infiltrative fibrosarcomas in cats using an anti-α v  β 3 integrin molecular probe",
      "author" : [ "CH Wenk", "F Ponce", "S Guillermet" ],
      "venue" : "Cancer Lett. 2013;334(2):188–195",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2013
    }, {
      "title" : "Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance",
      "author" : [ "I Kareva", "DJ Waxman", "GL. Klement" ],
      "venue" : "Cancer Lett. 2015;358(2):100–106",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2015
    }, {
      "title" : "Nanoscale drug delivery for targeted chemotherapy",
      "author" : [ "Y Xin", "Q Huang", "JQ Tang" ],
      "venue" : "Cancer Lett",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2016
    }, {
      "title" : "Nanomedicine in cancer therapy: innovative trends and prospects",
      "author" : [ "E Blanco", "A Hsiao", "AP Mann", "MG Landry", "F Meric-Bernstam", "M. Ferrari" ],
      "venue" : "Cancer Sci",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2011
    }, {
      "title" : "Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know",
      "author" : [ "C D’Antonio", "A Milano", "R Righini" ],
      "venue" : "Anticancer Res",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2014
    }, {
      "title" : "A systematic review of utility values for chemotherapy-related adverse events. Pharmacoeconomics",
      "author" : [ "FH Shabaruddin", "LC Chen", "RA Elliott", "K. Payne" ],
      "venue" : null,
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2013
    }, {
      "title" : "Late side effects and quality of life after radiotherapy for rectal cancer",
      "author" : [ "K Bruheim", "MG Guren", "E Skovlund" ],
      "venue" : "Int J Radiat Oncol",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2010
    }, {
      "title" : "Does preoperative radiotherapy with postoperative chemotherapy increase acute side-effects and postoperative complications of total mesorectal excision? Report of the randomized Finnish Rectal Cancer trial",
      "author" : [ "S Salmenkylä", "M Kouri", "P Osterlund" ],
      "venue" : "Scand J Surg",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2012
    }, {
      "title" : "Nanotechnology and nanomedicine: a primer",
      "author" : [ "Walker B Jr.", "Mouton CP" ],
      "venue" : "J Natl Med Assoc",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2006
    }, {
      "title" : "Inhibition of notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation",
      "author" : [ "P Grudzien", "S Lo", "KS Albain" ],
      "venue" : "Anticancer Res",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2010
    }, {
      "title" : "Nanoparticles: pharmacological and toxicological significance",
      "author" : [ "C Medina", "MJ Santos-Martinez", "A Radomski", "OI Corrigan", "MW. Radomski" ],
      "venue" : "Br J Pharmacol",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2007
    }, {
      "title" : "Nanomedicine: current status and future prospects",
      "author" : [ "SM Moghimi", "AC Hunter", "JC. Murray" ],
      "venue" : "FASEB J. 2005;19(3):311–330",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2005
    }, {
      "title" : "Effects of grain size and thermodynamic energy on the lattice parameters of metallic nanomaterials",
      "author" : [ "XH Yu", "J Rong", "ZL Zhan", "Z Liu", "JX. Liu" ],
      "venue" : "Mater Des",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2015
    }, {
      "title" : "Multicolor imaging of lymphatic function with two nanomaterials: quantum dotlabeled cancer cells and dendrimer-based optical agents",
      "author" : [ "H Kobayashi", "M Ogawa", "N Kosaka", "PL Choyke", "Y. Urano" ],
      "venue" : "Nanomedicine (Lond)",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2009
    }, {
      "title" : "Multifunctional nanoparticles possessing a “magnetic motor effect” for drug or gene",
      "author" : [ "TJ Yoon", "JS Kim", "BG Kim", "KN Yu", "MH Cho", "JK. Lee" ],
      "venue" : null,
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2005
    }, {
      "title" : "Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery",
      "author" : [ "F Tang", "L Li", "D. Chen" ],
      "venue" : "Adv Mater",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2012
    }, {
      "title" : "Nanoparticles target distinct dendritic cell populations according to their size",
      "author" : [ "V Manolova", "A Flace", "M Bauer", "K Schwarz", "P Saudan", "MF. Bachmann" ],
      "venue" : "Eur J Immunol",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2008
    }, {
      "title" : "The redoxactive nanomaterial toolbox for cancer therapy",
      "author" : [ "IL Ibanez", "C Notcovich", "PN Catalano", "MG Bellino", "H. Duran" ],
      "venue" : "Cancer Lett",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2015
    }, {
      "title" : "Glucose sensors based on core-shell magnetic nanomaterials and their application in diabetes management: a review",
      "author" : [ "L Liu", "HY Lv", "ZY Teng", "CY Wang", "GX. Wang" ],
      "venue" : "Curr Pharm Des",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2015
    }, {
      "title" : "Inhibitory effect of silver nanomaterials on transmissible virus-induced host cell infections",
      "author" : [ "XN Lv", "P Wang", "R Bai" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2014
    }, {
      "title" : "Nanotoxicity: the growing need for in vivo study",
      "author" : [ "Fischer HC", "Chan WC" ],
      "venue" : "Curr Opin Biotech",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2007
    }, {
      "title" : "Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages",
      "author" : [ "FL Ahsan", "IP Rivas", "MA Khan", "AI. Suarez" ],
      "venue" : "J Control Release",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2002
    }, {
      "title" : "Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells",
      "author" : [ "BD Chithrani", "AA Ghazani", "WC. Chan" ],
      "venue" : null,
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2006
    }, {
      "title" : "Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers",
      "author" : [ "JA Champion", "YK Katare", "S. Mitragotri" ],
      "venue" : "J Control Release",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2007
    }, {
      "title" : "Janus colloidal particles: preparation, properties, and biomedical applications",
      "author" : [ "C Kaewsaneha", "P Tangboriboonrat", "D Polpanich", "M Eissa", "A. Elaissari" ],
      "venue" : "ACS Appl Mater Interfaces",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2013
    }, {
      "title" : "Extraction of rutin and rhoifolin by inorganic borate functionalized magnetic particles",
      "author" : [ "Y Huang", "A Qi", "BH. Han" ],
      "venue" : "Chin J Chem",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2016
    }, {
      "title" : "Therapeutic nanoparticles for drug delivery in cancer",
      "author" : [ "K Cho", "X Wang", "S Nie", "Z Chen", "DM. Shin" ],
      "venue" : "Clin Cancer Res",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2008
    }, {
      "title" : "Drug delivery and nanoparticles: applications and hazards",
      "author" : [ "De Jong WH", "Borm PJ" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2008
    }, {
      "title" : "Detecting and treating cancer with nanotechnology",
      "author" : [ "KB Hartman", "LJ Wilson", "MG. Rosenblum" ],
      "venue" : "Mol Diagn Ther",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2008
    }, {
      "title" : "Are quantum dots ready for in vivo imaging in human subjects",
      "author" : [ "W Cai", "AR Hsu", "ZB Li", "X. Chen" ],
      "venue" : null,
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2007
    }, {
      "title" : "Nanoplatforms for targeted molecular imaging in living subjects",
      "author" : [ "W Cai", "X. Chen" ],
      "venue" : null,
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2007
    }, {
      "title" : "Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the bloodbrain barrier: a siRNA-chitosan approach",
      "author" : [ "J Malmo", "A Sandvig", "KM Vårum", "SP. Strand" ],
      "venue" : "PLoS One",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2013
    }, {
      "title" : "Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice",
      "author" : [ "LA Mitchell", "FT Lauer", "SW Burchiel", "JD. McDonald" ],
      "venue" : "Nat Nanotechnol",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2009
    }, {
      "title" : "Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure",
      "author" : [ "AV Tkach", "GV Shurin", "MR Shurin" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 2011
    }, {
      "title" : "Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes",
      "author" : [ "LA Mitchell", "J Gao", "RV Wal", "A Gigliotti", "SW Burchiel", "JD. McDonald" ],
      "venue" : "Toxicol Sci",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2007
    }, {
      "title" : "Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer",
      "author" : [ "HF Liang", "CT Chen", "SC Chen" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 2006
    }, {
      "title" : "Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes",
      "author" : [ "L Zhu", "Z Huo", "L Wang", "X Tong", "Y Xiao", "K. Ni" ],
      "venue" : "Int J Pharm",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2009
    }, {
      "title" : "PEG-modified gold nanorods with a stealth character for in vivo applications",
      "author" : [ "T Niidome", "M Yamagata", "Y Okamoto" ],
      "venue" : "J Control Release",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2006
    }, {
      "title" : "CMCTS stabilized Fe 3  O 4  particles with extremely low toxicity as highly efficient near-infrared photothermal agents for in vivo tumor",
      "author" : [ "S Shen", "FF Kong", "XM Guo" ],
      "venue" : "ablation. Nanoscale",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2013
    }, {
      "title" : "Nanoparticles: functionalization and multifunctional applications in biomedical sciences",
      "author" : [ "R Subbiah", "M Veerapandian", "KS. Yun" ],
      "venue" : "Curr Med Chem",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2010
    }, {
      "title" : "Influence of iron oleate complex structure on iron oxide nanoparticle formation",
      "author" : [ "LM Bronstein", "XL Huang", "J Retrum" ],
      "venue" : "Chem Mater",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2007
    }, {
      "title" : "Surfactant-free synthesis and functionalization of gold nanoparticles",
      "author" : [ "M Schulz-Dobrick", "KV Sarathy", "M. Jansen" ],
      "venue" : "J Am Chem Soc",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2005
    }, {
      "title" : "Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells",
      "author" : [ "JY Chen", "DL Wang", "JF Xi" ],
      "venue" : null,
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2007
    }, {
      "title" : "High temperature decomposition of cerium precursors to form ceria nanocrystal libraries for biological applications",
      "author" : [ "SS Lee", "H Zhu", "EQ Contreras", "A Prakash", "HL Puppala", "VL. Colvin" ],
      "venue" : "Chem Mater",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2012
    }, {
      "title" : "Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance",
      "author" : [ "LR Hirsch", "RJ Stafford", "JA Bankson" ],
      "venue" : "Proc Natl Acad Sci U S A",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2003
    }, {
      "title" : "Novel hyperthermia for metastatic bone tumors with magnetic materials by generating an alternating electromagnetic field",
      "author" : [ "A Matsumine", "K Kusuzaki", "T Matsubara" ],
      "venue" : "Clin Exp Metastasis",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2007
    }, {
      "title" : "Characterization of interaction of magnetic nanoparticles with breast cancer cells",
      "author" : [ "M Calero", "M Chiappi", "A Lazaro-Carrillo" ],
      "venue" : "J Nanobiotechnology",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2015
    }, {
      "title" : "HER-2mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization",
      "author" : [ "SC Wuang", "KG Neoh", "ET Kang", "DW Pack", "DE. Leckband" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2008
    }, {
      "title" : "Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers",
      "author" : [ "Wahajuddin", "Arora S" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2012
    }, {
      "title" : "Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology",
      "author" : [ "CY Yang", "MF Tai", "CP Lin" ],
      "venue" : "PLoS One",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2011
    }, {
      "title" : "Applications and potential toxicity of magnetic iron oxide nanoparticles",
      "author" : [ "G Liu", "J Gao", "H Ai", "X. Chen" ],
      "venue" : null,
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2013
    }, {
      "title" : "Iron oxide particles for atheroma imaging",
      "author" : [ "TY Tang", "KH Muller", "MJ Graves" ],
      "venue" : "Arterioscler Throm Vasc Biol",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2009
    }, {
      "title" : "PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue",
      "author" : [ "W Eck", "G Craig", "A Sigdel" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2008
    }, {
      "title" : "The surface functionalisation of gold nanoparticles with metal complexes",
      "author" : [ "Wilton-Ely JD" ],
      "venue" : "Dalton Trans",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2008
    }, {
      "title" : "Facile and green fabrication of size-controlled AuNPs/CNFs hybrids for the highly sensitive simultaneous detection of heavy metal ions",
      "author" : [ "B Zhang", "JD Chen", "H Zhu" ],
      "venue" : "Electrochim Acta",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2016
    }, {
      "title" : "Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin",
      "author" : [ "SD Brown", "P Nativo", "JA Smith" ],
      "venue" : "J Am Chem Soc",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2010
    }, {
      "title" : "Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer",
      "author" : [ "A Llevot", "D. Astruc" ],
      "venue" : "Chem Soc Rev",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2012
    }, {
      "title" : "Recent advances of chitosan nanoparticles as drug carriers",
      "author" : [ "JJ Wang", "ZW Zeng", "RZ Xiao" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2011
    }, {
      "title" : "Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice",
      "author" : [ "JV Jokerst", "AJ Cole", "D Van de Sompel", "SS. Gambhir" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 2012
    }, {
      "title" : "Recent advances of chitosan nanoparticles as drug carriers",
      "author" : [ "JJ Wang", "ZW Zeng", "RZ Xiao" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2011
    }, {
      "title" : "Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles",
      "author" : [ "A Verma", "O Uzun", "Y Hu" ],
      "venue" : "Nat Mater",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2008
    }, {
      "title" : "Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders",
      "author" : [ "H Laroui", "P Rakhya", "B Xiao", "E Viennois", "D. Merlin" ],
      "venue" : "Dig Liver Dis",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2013
    }, {
      "title" : "Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer",
      "author" : [ "P Fortina", "LJ Kricka", "DJ Graves" ],
      "venue" : "Trends Biotechnol",
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2007
    }, {
      "title" : "Gold nanoparticles downregulate interleukin-1-induced pro-inflammatory responses",
      "author" : [ "VV Sumbayev", "IM Yasinska", "CP Garcia" ],
      "venue" : null,
      "citeRegEx" : "77",
      "shortCiteRegEx" : "77",
      "year" : 2013
    }, {
      "title" : "In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice",
      "author" : [ "H Chen", "A Dorrigan", "S Saad", "DJ Hare", "MB Cortie", "SM. Valenzuela" ],
      "venue" : "PLoS One",
      "citeRegEx" : "78",
      "shortCiteRegEx" : "78",
      "year" : 2013
    }, {
      "title" : "Catalytic properties and biomedical applications of cerium oxide nanoparticles",
      "author" : [ "C Walkey", "S Das", "S Seal" ],
      "venue" : "Environ Sci Nano",
      "citeRegEx" : "79",
      "shortCiteRegEx" : "79",
      "year" : 2015
    }, {
      "title" : "Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity",
      "author" : [ "M Pešić", "A Podolski-Renić", "S Stojković" ],
      "venue" : null,
      "citeRegEx" : "80",
      "shortCiteRegEx" : "80",
      "year" : 2015
    }, {
      "title" : "Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression",
      "author" : [ "YF Xiao", "JM Li", "SM Wang" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2016
    }, {
      "title" : "Nanocrystal targeting in vivo",
      "author" : [ "ME Akerman", "WC Chan", "P Laakkonen", "SN Bhatia", "E. Ruoslahti" ],
      "venue" : "Proc Natl Acad Sci U S A",
      "citeRegEx" : "82",
      "shortCiteRegEx" : "82",
      "year" : 2002
    }, {
      "title" : "Nanotechnology platforms and physiological challenges for cancer",
      "author" : [ "Kim KY" ],
      "venue" : "therapeutics. Nanomedicine",
      "citeRegEx" : "83",
      "shortCiteRegEx" : "83",
      "year" : 2007
    }, {
      "title" : "Noninvasive imaging of quantum dots in mice",
      "author" : [ "B Ballou", "BC Lagerholm", "LA Ernst", "MP Bruchez", "AS. Waggoner" ],
      "venue" : "Bioconjug Chem",
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2004
    }, {
      "title" : "Recent advances in basic and clinical nanomedicine",
      "author" : [ "Jr Morrow KJ", "R Bawa", "C. Wei" ],
      "venue" : "Med Clin North Am",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2007
    }, {
      "title" : "Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer",
      "author" : [ "P Juzenas", "W Chen", "YP Sun" ],
      "venue" : "Adv Drug Deliv Rev",
      "citeRegEx" : "86",
      "shortCiteRegEx" : "86",
      "year" : 2008
    }, {
      "title" : "Fullerene (C 60  ) immunoconjugates: interaction of water-soluble C 60  derivatives with the murine anti-gp240 melanoma antibody",
      "author" : [ "JM Ashcroft", "DA Tsyboulski", "KB Hartman" ],
      "venue" : "Chem Commun",
      "citeRegEx" : "87",
      "shortCiteRegEx" : "87",
      "year" : 2006
    }, {
      "title" : "Functionalized carbon nanotubes in drug design and discovery",
      "author" : [ "M Prato", "K Kostarelos", "A. Bianco" ],
      "venue" : "Acc Chem Res",
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2008
    }, {
      "title" : "Translocation of C 60 and its derivatives across a lipid bilayer",
      "author" : [ "R Qiao", "AP Roberts", "AS Mount", "SJ Klaine", "PC. Ke" ],
      "venue" : null,
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2007
    }, {
      "title" : "Pharmacological studies on fullerene (C 60  ), a novel carbon allotrope, and its derivatives",
      "author" : [ "M Satoh", "I. Takayanagi" ],
      "venue" : "J Pharmacol Sci",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2006
    }, {
      "title" : "One-dimensional metallofullerene crystal generated inside single-walled carbon nanotubes",
      "author" : [ "K Hirahara", "K Suenaga", "S Bandow" ],
      "venue" : "Phys Rev Lett",
      "citeRegEx" : "91",
      "shortCiteRegEx" : "91",
      "year" : 2000
    }, {
      "title" : "Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis",
      "author" : [ "XJ Liang", "H Meng", "Y Wang" ],
      "venue" : "Proc Natl Acad Sci U S A. 2010;107(16):7449–7454.  International Journal of Nanomedicine 2017:12  submit your manuscript | www.dovepress.com Dovepress Dovepress",
      "citeRegEx" : "92",
      "shortCiteRegEx" : "92",
      "year" : 2017
    }, {
      "title" : "Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus",
      "author" : [ "AA Shvedova", "ER Kisin", "D Porter" ],
      "venue" : "Pharmacol Ther",
      "citeRegEx" : "93",
      "shortCiteRegEx" : "93",
      "year" : 2009
    }, {
      "title" : "The carbon nanocosmos: novel materials for the twenty-first century",
      "author" : [ "M Terrones", "H. Terrones" ],
      "venue" : "Philos Trans A Math Phys Eng Sci",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 2003
    }, {
      "title" : "Carbon nanotubes as nanomedicines: from toxicology to pharmacology",
      "author" : [ "L Lacerda", "A Bianco", "M Prato", "K. Kostarelos" ],
      "venue" : "Adv Drug Deliv Rev",
      "citeRegEx" : "95",
      "shortCiteRegEx" : "95",
      "year" : 2006
    }, {
      "title" : "Raman spectroscopy as a detection and analysis tool for in vitro specific targeting of pancreatic cancer cells by EGF-conjugated, single-walled carbon nanotubes",
      "author" : [ "A Karmakar", "C Iancu", "DM Bartos" ],
      "venue" : "J Appl Toxicol",
      "citeRegEx" : "96",
      "shortCiteRegEx" : "96",
      "year" : 2012
    }, {
      "title" : "Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and antitumor drug",
      "author" : [ "M Mahmood", "A Karmakar", "A Fejleh" ],
      "venue" : "Nanomedicine (Lond)",
      "citeRegEx" : "97",
      "shortCiteRegEx" : "97",
      "year" : 2009
    }, {
      "title" : "Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable",
      "author" : [ "H Shen", "AL Ackerman", "V Cody" ],
      "venue" : "nanoparticles. Immunology",
      "citeRegEx" : "98",
      "shortCiteRegEx" : "98",
      "year" : 2006
    }, {
      "title" : "Nanotechnology and cancer",
      "author" : [ "Heath JR", "Davis ME" ],
      "venue" : "Annu Rev Med",
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 2008
    }, {
      "title" : "Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles",
      "author" : [ "DP O’Neal", "LR Hirsch", "NJ Halas", "JD Payne", "JL. West" ],
      "venue" : "Cancer Lett. 2004;209(2):171–176",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 2004
    }, {
      "title" : "Surface plasmon resonance-induced photoactivation of gold nanoparticles as mitochondria-targeted therapeutic agents for pancreatic cancer",
      "author" : [ "L Mocan", "I Ilie", "FA Tabaran" ],
      "venue" : "Expert Opin Ther Targets",
      "citeRegEx" : "101",
      "shortCiteRegEx" : "101",
      "year" : 2013
    }, {
      "title" : "Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubes",
      "author" : [ "L Mocan", "FA Tabaran", "T Mocan" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "102",
      "shortCiteRegEx" : "102",
      "year" : 2011
    }, {
      "title" : "Photothermal treatment of human pancreatic cancer using PEGylated multi-walled carbon nanotubes induces apoptosis by triggering mitochondrial membrane depolarization mechanism",
      "author" : [ "T Mocan", "CT Matea", "I Cojocaru" ],
      "venue" : "J Cancer",
      "citeRegEx" : "103",
      "shortCiteRegEx" : "103",
      "year" : 2014
    }, {
      "title" : "Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction",
      "author" : [ "NW Kam", "M O’Connell", "JA Wisdom", "HJ. Dai" ],
      "venue" : "Proc Natl Acad Sci U S A",
      "citeRegEx" : "104",
      "shortCiteRegEx" : "104",
      "year" : 2005
    }, {
      "title" : "Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes. Nanotechnology",
      "author" : [ "N Shao", "S Lu", "E Wickstrom", "B. Panchapakesan" ],
      "venue" : null,
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2007
    }, {
      "title" : "Nanophotothermolysis of multiple scattered cancer cells with carbon nanotubes guided by time-resolved infrared thermal imaging",
      "author" : [ "AS Biris", "D Boldor", "J Palmer" ],
      "venue" : "J Biomed Opt",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2009
    }, {
      "title" : "Hyperthermic effect of multiwalled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies",
      "author" : [ "A Burlaka", "S Lukin", "S Prylutska" ],
      "venue" : "Exp Oncol",
      "citeRegEx" : "107",
      "shortCiteRegEx" : "107",
      "year" : 2010
    }, {
      "title" : "Electric field effect in atomically thin carbon",
      "author" : [ "KS Novoselov", "AK Geim", "SV Morozov" ],
      "venue" : "films. Science",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2004
    }, {
      "title" : "Graphene: the new two-dimensional nanomaterial",
      "author" : [ "CN Rao", "AK Sood", "KS Subrahmanyam", "A. Govindaraj" ],
      "venue" : "Angew Chem Int Ed Engl",
      "citeRegEx" : "109",
      "shortCiteRegEx" : "109",
      "year" : 2009
    }, {
      "title" : "Honeycomb carbon: a review of graphene",
      "author" : [ "MJ Allen", "VC Tung", "RB. Kaner" ],
      "venue" : "Chem Rev",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2010
    }, {
      "title" : "Nano-graphene in biomedicine: theranostic applications",
      "author" : [ "K Yang", "LZ Feng", "XZ Shi", "Z. Liu" ],
      "venue" : "Chem Soc Rev",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2013
    }, {
      "title" : "Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles",
      "author" : [ "K Yang", "LL Hu", "XX Ma" ],
      "venue" : "Adv Mater",
      "citeRegEx" : "112",
      "shortCiteRegEx" : "112",
      "year" : 2012
    }, {
      "title" : "Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy",
      "author" : [ "K Yang", "SA Zhang", "GX Zhang", "XM Sun", "ST Lee", "ZA. Liu" ],
      "venue" : null,
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2010
    }, {
      "title" : "The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials",
      "author" : [ "K Yang", "JM Wan", "S Zhang", "B Tian", "YJ Zhang", "Z. Liu" ],
      "venue" : null,
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2012
    }, {
      "title" : "Ultrasmall gold nanoparticles anchored to graphene and enhanced photothermal effects by laser irradiation of gold nanostructures in graphene oxide solutions",
      "author" : [ "AF Zedan", "S Moussa", "J Terner", "G Atkinson", "MS. El-Shall" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "115",
      "shortCiteRegEx" : "115",
      "year" : 2013
    }, {
      "title" : "Gold nanorod-assembled PEGylated graphene-oxide nanocomposites for photothermal cancer therapy",
      "author" : [ "U Dembereldorj", "SY Choi", "EO Ganbold" ],
      "venue" : "Photochem Photobiol",
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2014
    }, {
      "title" : "A tumor-targeting near-infrared lasertriggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging",
      "author" : [ "JJ Shi", "L Wang", "J Zhang" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 2014
    }, {
      "title" : "Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy",
      "author" : [ "J Bai", "YW Liu", "XE. Jiang" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2014
    }, {
      "title" : "Facile synthesis of water-dispersible Cu 2  O nanocrystal-reduced graphene oxide hybrid as a promising cancer therapeutic agent",
      "author" : [ "CY Hou", "HC Quan", "YR Duan", "QH Zhang", "HZ Wang", "YG. Li" ],
      "venue" : null,
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2013
    }, {
      "title" : "Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis",
      "author" : [ "AM Friedhuber", "V Chandolu", "S Manchun", "O Donkor", "P Sriamornsak", "CR. Dass" ],
      "venue" : "J Pharm Pharmacol",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2015
    }, {
      "title" : "Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells",
      "author" : [ "SF Shi", "JF Jia", "XK Guo" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2012
    }, {
      "title" : "Biomedical applications of carboxymethyl chitosans",
      "author" : [ "L Upadhyaya", "J Singh", "V Agarwal", "RP. Tewari" ],
      "venue" : "Carbohydr Polym",
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2013
    }, {
      "title" : "Preparation and characterization of chitosan-based nanoparticles",
      "author" : [ "M Bodnar", "JF Hartmann", "J. Borbely" ],
      "venue" : "Biomacromolecules",
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2005
    }, {
      "title" : "Nanostructured materials for applications in drug delivery and tissue engineering",
      "author" : [ "M Goldberg", "R Langer", "X. Jia" ],
      "venue" : "J Biomater Sci Polym Ed",
      "citeRegEx" : "124",
      "shortCiteRegEx" : "124",
      "year" : 2007
    }, {
      "title" : "Chitosan-based delivery systems for protein therapeutics and antigens",
      "author" : [ "M Amidi", "E Mastrobattista", "W Jiskoot", "WE. Hennink" ],
      "venue" : "Adv Drug Deliv Rev",
      "citeRegEx" : "125",
      "shortCiteRegEx" : "125",
      "year" : 2010
    }, {
      "title" : "Emerging nanopharmaceuticals. Nanomedicine",
      "author" : [ "WE Bawarski", "E Chidlowsky", "DJ Bharali", "SA. Mousa" ],
      "venue" : null,
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2008
    }, {
      "title" : "Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine",
      "author" : [ "Seferian PG", "Martinez ML" ],
      "venue" : null,
      "citeRegEx" : "127",
      "shortCiteRegEx" : "127",
      "year" : 2000
    }, {
      "title" : "Alveolar macrophage priming by intravenous administration of chitin particles, polymers of n-acetyl-d-glucosamine, in mice",
      "author" : [ "Y Shibata", "LA Foster", "WJ Metzger", "QN. Myrvik" ],
      "venue" : "Infect Immun",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 1997
    }, {
      "title" : "Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines",
      "author" : [ "P Calvo", "C Remuñan-López", "JL VilaJato", "MJ. Alonso" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "129",
      "shortCiteRegEx" : "129",
      "year" : 1997
    }, {
      "title" : "Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro",
      "author" : [ "YI Jeong", "SG Jin", "IY Kim" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "130",
      "shortCiteRegEx" : "130",
      "year" : 2010
    }, {
      "title" : "Promises, facts and challenges for carbon nanotubes in imaging and therapeutics",
      "author" : [ "K Kostarelos", "A Bianco", "M. Prato" ],
      "venue" : "Nat Nanotechnol",
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2009
    }, {
      "title" : "Nanoscale environmental science and technology: challenges and opportunities",
      "author" : [ "WX Zhang", "B. Karn" ],
      "venue" : "Environ Sci Technol",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2005
    }, {
      "title" : "Biomedical applications and potential health risks of nanomaterials: molecular mechanisms",
      "author" : [ "S Lanone", "J. Boczkowski" ],
      "venue" : "Curr Mol Med",
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2017
    }, {
      "title" : "Toxicity of nanocrystal quantum dots: the relevance of surface modifications",
      "author" : [ "A Hoshino", "S Hanada", "K. Yamamoto" ],
      "venue" : "Arch Toxicol",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2011
    }, {
      "title" : "Yellow light for nanotech",
      "author" : [ "F. Proffitt" ],
      "venue" : null,
      "citeRegEx" : "135",
      "shortCiteRegEx" : "135",
      "year" : 2004
    }, {
      "title" : "Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation",
      "author" : [ "CW Lam", "JT James", "R McCluskey", "RL. Hunter" ],
      "venue" : "Toxicol Sci",
      "citeRegEx" : "136",
      "shortCiteRegEx" : "136",
      "year" : 2004
    }, {
      "title" : "A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks",
      "author" : [ "CW Lam", "JT James", "R McCluskey", "S Arepalli", "RL. Hunter" ],
      "venue" : "Crit Rev Toxicol",
      "citeRegEx" : "138",
      "shortCiteRegEx" : "138",
      "year" : 2006
    }, {
      "title" : "Toxic potential of materials at the nanolevel",
      "author" : [ "A Nel", "T Xia", "L Madler", "N. Li" ],
      "venue" : null,
      "citeRegEx" : "139",
      "shortCiteRegEx" : "139",
      "year" : 2006
    }, {
      "title" : "Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-κB in human keratinocytes",
      "author" : [ "SK Manna", "S Sarkar", "J Barr" ],
      "venue" : null,
      "citeRegEx" : "140",
      "shortCiteRegEx" : "140",
      "year" : 2005
    }, {
      "title" : "Multiwalled carbon nanotubes activate NF-κB and AP-1 signaling pathways to induce apoptosis in rat lung epithelial cells",
      "author" : [ "P Ravichandran", "S Baluchamy", "B Sadanandan" ],
      "venue" : null,
      "citeRegEx" : "141",
      "shortCiteRegEx" : "141",
      "year" : 2010
    }, {
      "title" : "Effect of single wall carbon nanotubes on human HEK293 cells",
      "author" : [ "DX Cui", "FR Tian", "CS Ozkan", "M Wang", "HJ. Gao" ],
      "venue" : "Toxicol Lett",
      "citeRegEx" : "142",
      "shortCiteRegEx" : "142",
      "year" : 2005
    }, {
      "title" : "Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types",
      "author" : [ "LC Renwick", "D Brown", "A Clouter", "K. Donaldson" ],
      "venue" : "Occup Environ Med",
      "citeRegEx" : "143",
      "shortCiteRegEx" : "143",
      "year" : 2004
    }, {
      "title" : "Sugar-functionalized triptycenes used for dispersion of single-walled carbon nanotubes in aqueous solution by supramolecular interaction",
      "author" : [ "H Li", "Q Chen", "BH. Han" ],
      "venue" : "New J Chem",
      "citeRegEx" : "144",
      "shortCiteRegEx" : "144",
      "year" : 2016
    }, {
      "title" : "Molecular dynamics simulation of non-covalent single-walled carbon nanotube functionalization with surfactant peptides",
      "author" : [ "A Barzegar", "A Mansouri", "J. Azamat" ],
      "venue" : "J Mol Graph",
      "citeRegEx" : "145",
      "shortCiteRegEx" : "145",
      "year" : 2016
    }, {
      "title" : "Development of functionalized single walled carbon nanotubes based triacylglycerol acylhydrolases",
      "author" : [ "Ali K", "Mahmoud WE" ],
      "venue" : null,
      "citeRegEx" : "146",
      "shortCiteRegEx" : "146",
      "year" : 2013
    }, {
      "title" : "Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine",
      "author" : [ "Firme CP 3rd", "Bandaru PR" ],
      "venue" : null,
      "citeRegEx" : "147",
      "shortCiteRegEx" : "147",
      "year" : 2010
    } ],
    "referenceMentions" : [ {
      "referenceID" : 1,
      "context" : "Either tumor-suppressor genes are inactivated or oncogenes are activated, which leads to malignant proliferation of tumor cells, tissue infiltration, and organ dysfunction.(2) Many methods have been developed for tumor therapy, such as immunotherapy,(3,4) gene therapy,(5,6) and radiofrequency ablation (RFA).",
      "startOffset" : 172,
      "endOffset" : 175
    }, {
      "referenceID" : 16,
      "context" : "However, chemotherapy has a number of problems, including nonspecific distribution of the drug and the lack of tumor-specific treatments.(17) In the continuous fight against",
      "startOffset" : 137,
      "endOffset" : 141
    }, {
      "referenceID" : 17,
      "context" : "Chemotherapy also causes side effects in healthy tissues, which have negative impacts on the quality of life of the patients.(18,19) In addi-",
      "startOffset" : 125,
      "endOffset" : 132
    }, {
      "referenceID" : 18,
      "context" : "Chemotherapy also causes side effects in healthy tissues, which have negative impacts on the quality of life of the patients.(18,19) In addi-",
      "startOffset" : 125,
      "endOffset" : 132
    }, {
      "referenceID" : 19,
      "context" : "tion, chemotherapy may concomitantly damage adjacent organs or tissues, and these adverse effects are difficult to avoid.(20,21)",
      "startOffset" : 121,
      "endOffset" : 128
    }, {
      "referenceID" : 20,
      "context" : "tion, chemotherapy may concomitantly damage adjacent organs or tissues, and these adverse effects are difficult to avoid.(20,21)",
      "startOffset" : 121,
      "endOffset" : 128
    }, {
      "referenceID" : 22,
      "context" : "The term “nano-” is derived from the Greek noun nanos,(22) and a nanometer (nm) is equivalent to 10-9 m.(23) The specific physical and/or chemical properties of NMs make them very attractive in biomedical applications.",
      "startOffset" : 104,
      "endOffset" : 108
    }, {
      "referenceID" : 23,
      "context" : "The specific physical and/or chemical properties of NMs make them very attractive in biomedical applications.(24,25) Over the past few decades, the explosion of studies involving NMs can be ascribed to their special optical, thermodynamic, magnetic, and mechanical properties.",
      "startOffset" : 109,
      "endOffset" : 116
    }, {
      "referenceID" : 24,
      "context" : "The specific physical and/or chemical properties of NMs make them very attractive in biomedical applications.(24,25) Over the past few decades, the explosion of studies involving NMs can be ascribed to their special optical, thermodynamic, magnetic, and mechanical properties.",
      "startOffset" : 109,
      "endOffset" : 116
    }, {
      "referenceID" : 28,
      "context" : "Potential medical applications of NMs have been recognized to have good biocompatibility.(29) Nanoparticles (NPs) with suitable diameter range have been",
      "startOffset" : 89,
      "endOffset" : 93
    }, {
      "referenceID" : 29,
      "context" : "reported to be able to enter blood circulation and undergo endocytosis into cells.(30) Furthermore, scientific research",
      "startOffset" : 82,
      "endOffset" : 86
    }, {
      "referenceID" : 26,
      "context" : "The physical and chemical properties of NMs impact on biodistribution, cellular processes, and cytotoxic effects.(27,34,35)",
      "startOffset" : 113,
      "endOffset" : 123
    }, {
      "referenceID" : 33,
      "context" : "The physical and chemical properties of NMs impact on biodistribution, cellular processes, and cytotoxic effects.(27,34,35)",
      "startOffset" : 113,
      "endOffset" : 123
    }, {
      "referenceID" : 34,
      "context" : "The physical and chemical properties of NMs impact on biodistribution, cellular processes, and cytotoxic effects.(27,34,35)",
      "startOffset" : 113,
      "endOffset" : 123
    }, {
      "referenceID" : 35,
      "context" : "For example, the size of the NM affects cellular tropism by facilitating or inhibiting actin polymerization.(36) In addition",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 36,
      "context" : "to size, the shape of NMs influences organ and cellular tropism.(37) Spherical NMs promote phagocytosis of mac-",
      "startOffset" : 64,
      "endOffset" : 68
    }, {
      "referenceID" : 37,
      "context" : "design new biomedical applications, which include various clinical and research activities and modulation of processes in target cells.(38) With the development of nanotechnology, the integration of NMs into tumor therapeutics is one of the rapidly advancing fields, and more new NMs will be increasingly used in the field of tumor treatment.",
      "startOffset" : 135,
      "endOffset" : 139
    }, {
      "referenceID" : 44,
      "context" : "nally active, and can stimulate a strong immune response in the body.(45) Some NMs can kill or inhibit pathogenic cell",
      "startOffset" : 69,
      "endOffset" : 73
    }, {
      "referenceID" : 48,
      "context" : "used as potential antitumor drugs, and are being developed as photothermal therapy (PTT) agents.(49,50) Therefore, this",
      "startOffset" : 96,
      "endOffset" : 103
    }, {
      "referenceID" : 49,
      "context" : "used as potential antitumor drugs, and are being developed as photothermal therapy (PTT) agents.(49,50) Therefore, this",
      "startOffset" : 96,
      "endOffset" : 103
    }, {
      "referenceID" : 50,
      "context" : "readily prepared, have surfaces relatively easy to modify, and in general have low toxicity.(51,52) Because of their unique",
      "startOffset" : 92,
      "endOffset" : 99
    }, {
      "referenceID" : 51,
      "context" : "readily prepared, have surfaces relatively easy to modify, and in general have low toxicity.(51,52) Because of their unique",
      "startOffset" : 92,
      "endOffset" : 99
    }, {
      "referenceID" : 40,
      "context" : "their ability to interact directly with cell membranes and intracellular structures.(41,42) As discussed earlier, these special properties make MNMs useful for numerous diagnostic and therapeutic applications.",
      "startOffset" : 84,
      "endOffset" : 91
    }, {
      "referenceID" : 41,
      "context" : "their ability to interact directly with cell membranes and intracellular structures.(41,42) As discussed earlier, these special properties make MNMs useful for numerous diagnostic and therapeutic applications.",
      "startOffset" : 84,
      "endOffset" : 91
    }, {
      "referenceID" : 52,
      "context" : "As discussed earlier, these special properties make MNMs useful for numerous diagnostic and therapeutic applications.(53) Most MNMs for tumor therapy consist of iron oxide, gold NPs, and cerium oxide NPs (Figure 2).",
      "startOffset" : 117,
      "endOffset" : 121
    }, {
      "referenceID" : 57,
      "context" : "PTT is based on using optical heating to facilitate direct and specific destruction of tumor cells.(58) PTT is a highly promising approach to tumor therapy.",
      "startOffset" : 99,
      "endOffset" : 103
    }, {
      "referenceID" : 25,
      "context" : "In addition to PTT, potential medical applications of magnetic NPs have also been approved, due to their good biocompatibility.(26) According to a recent report, magnetic NPs with diameters ranging between several (~9 nm) and hundreds (~200 nm) of nanometers can circulate in blood",
      "startOffset" : 127,
      "endOffset" : 131
    }, {
      "referenceID" : 59,
      "context" : "vessels and undergo endocytosis into cells.(60) The authors also found that dimercaptosuccinic acid-coated iron oxide NPs have excellent potential for applications that target breast-tumor cells.",
      "startOffset" : 43,
      "endOffset" : 47
    }, {
      "referenceID" : 60,
      "context" : "There is a report of using anti-HER2-conjugated polypyrrole-Fe 3 O 4 NPs to target and damage SK-BR-3 breast tumor cells in vitro.(61) In fact, superparamagnetic iron oxide NPs (SPIONs; Fe 3 O 4 or Fe 2 O 3 )(62) have been recognized for clinical use in the form of ferucarbotran (carboxydextran SPIONs), ferumoxides (dextran SPIONs), and ferumoxtran 10 (dextran SPIONs).",
      "startOffset" : 130,
      "endOffset" : 134
    }, {
      "referenceID" : 62,
      "context" : "In fact, superparamagnetic iron oxide NPs (SPIONs; Fe 3 O 4 or Fe 2 O 3 )(62) have been recognized for clinical use in the form of ferucarbotran (carboxydextran SPIONs), ferumoxides (dextran SPIONs), and ferumoxtran 10 (dextran SPIONs).(63) These SPIONs are highly biodegradable and biocompatible; the iron core is recycled into soluble ferritin iron or hemosiderin.",
      "startOffset" : 236,
      "endOffset" : 240
    }, {
      "referenceID" : 63,
      "context" : "These SPIONs are highly biodegradable and biocompatible; the iron core is recycled into soluble ferritin iron or hemosiderin.(64) Iron oxide NPs are also intensively used in imaging system as contrast agents in pathophysiological studies.",
      "startOffset" : 125,
      "endOffset" : 129
    }, {
      "referenceID" : 64,
      "context" : "Iron oxide NPs are also intensively used in imaging system as contrast agents in pathophysiological studies.(65)",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 65,
      "context" : "Gold NMs In recent years, AuNMs have shown important potential in various biomedical and research applications, such as catalysis, bioanalysis, and imaging.(66,67) The preparation technology is simple, and it is easy to control the size and shape of AuNMs.",
      "startOffset" : 156,
      "endOffset" : 163
    }, {
      "referenceID" : 66,
      "context" : "Gold NMs In recent years, AuNMs have shown important potential in various biomedical and research applications, such as catalysis, bioanalysis, and imaging.(66,67) The preparation technology is simple, and it is easy to control the size and shape of AuNMs.",
      "startOffset" : 156,
      "endOffset" : 163
    }, {
      "referenceID" : 67,
      "context" : "The preparation technology is simple, and it is easy to control the size and shape of AuNMs.(68,69) It has been reported that AuNMs can selectively and specifically recognize tumor cells.",
      "startOffset" : 92,
      "endOffset" : 99
    }, {
      "referenceID" : 68,
      "context" : "The preparation technology is simple, and it is easy to control the size and shape of AuNMs.(68,69) It has been reported that AuNMs can selectively and specifically recognize tumor cells.",
      "startOffset" : 92,
      "endOffset" : 99
    }, {
      "referenceID" : 69,
      "context" : "It has been reported that AuNMs can selectively and specifically recognize tumor cells.(70,71) Studies reported in the literature have shown that AuNMs are easily functionalized, increase the time of circulation, and are stable in systemic circulation.",
      "startOffset" : 87,
      "endOffset" : 94
    }, {
      "referenceID" : 70,
      "context" : "It has been reported that AuNMs can selectively and specifically recognize tumor cells.(70,71) Studies reported in the literature have shown that AuNMs are easily functionalized, increase the time of circulation, and are stable in systemic circulation.",
      "startOffset" : 87,
      "endOffset" : 94
    }, {
      "referenceID" : 71,
      "context" : "Perhaps the most important property of AuNMs is their ability to destroy tumor cells.(72) Thus, such AuNMs as AuNPs(73,74) and gold nanocages(56) are a promising tool for selectively killing tumor cells through photothermal (PT) damage.",
      "startOffset" : 85,
      "endOffset" : 89
    }, {
      "referenceID" : 71,
      "context" : "can also enhance the effect of radiotherapy, which has been verified in vivo and in vitro in animal models of tumors.(72) AuNPs are commonly used as nanobioconjugates.",
      "startOffset" : 117,
      "endOffset" : 121
    }, {
      "referenceID" : 68,
      "context" : "AuNPs are commonly used as nanobioconjugates.(69,70,73) The",
      "startOffset" : 45,
      "endOffset" : 55
    }, {
      "referenceID" : 69,
      "context" : "AuNPs are commonly used as nanobioconjugates.(69,70,73) The",
      "startOffset" : 45,
      "endOffset" : 55
    }, {
      "referenceID" : 72,
      "context" : "AuNPs are commonly used as nanobioconjugates.(69,70,73) The",
      "startOffset" : 45,
      "endOffset" : 55
    }, {
      "referenceID" : 73,
      "context" : "nucleus, increasing the likelihood that the active cytostatic substance acts directly on DNA.(74) Studies reported in the",
      "startOffset" : 93,
      "endOffset" : 97
    }, {
      "referenceID" : 69,
      "context" : "literature have shown that multifunctional AuNPs can be used both to image and treat tumors.(70)",
      "startOffset" : 92,
      "endOffset" : 96
    }, {
      "referenceID" : 74,
      "context" : "Laroui et al developed nanoshells coated with gold, absorbing specific wavelengths of light.(75) Fortina et al synthesized nanoshells linked to a ligand.",
      "startOffset" : 92,
      "endOffset" : 96
    }, {
      "referenceID" : 75,
      "context" : "Fortina et al synthesized nanoshells linked to a ligand.(76) Citrate-coated gold has been shown to have antitumor properties.",
      "startOffset" : 56,
      "endOffset" : 60
    }, {
      "referenceID" : 76,
      "context" : "Citrate-coated gold has been shown to have antitumor properties.(77,78) Xia et al(56) synthesized novel gold nanocages ~45 nm in edge length.",
      "startOffset" : 64,
      "endOffset" : 71
    }, {
      "referenceID" : 77,
      "context" : "Citrate-coated gold has been shown to have antitumor properties.(77,78) Xia et al(56) synthesized novel gold nanocages ~45 nm in edge length.",
      "startOffset" : 64,
      "endOffset" : 71
    }, {
      "referenceID" : 78,
      "context" : "Cerium oxide nanoparticles Cerium oxide NPs include a cerium core surrounded by an oxygen lattice.(79) In normal cells, these NPs have an antioxidant and cytoprotective role under neutral pH.",
      "startOffset" : 98,
      "endOffset" : 102
    }, {
      "referenceID" : 79,
      "context" : "and the results showed that cerium oxide NPs inhibited the growth of tumor cells.(80) There has been another report indicating that a high concentration (10 μg/mL) of cerium",
      "startOffset" : 81,
      "endOffset" : 85
    }, {
      "referenceID" : 80,
      "context" : "oxide NPs can suppress tumor-cell migration and inhibit tumor-cell proliferation.(81)",
      "startOffset" : 81,
      "endOffset" : 85
    }, {
      "referenceID" : 39,
      "context" : "Quantum dots Another popular type of NM are QDs.(40) QDs are very small",
      "startOffset" : 48,
      "endOffset" : 52
    }, {
      "referenceID" : 43,
      "context" : "cific wavelength of light, and their diameter is approximately 2–10 nm.(44,82,83) Their structure consists of an inorganic core",
      "startOffset" : 71,
      "endOffset" : 81
    }, {
      "referenceID" : 81,
      "context" : "cific wavelength of light, and their diameter is approximately 2–10 nm.(44,82,83) Their structure consists of an inorganic core",
      "startOffset" : 71,
      "endOffset" : 81
    }, {
      "referenceID" : 82,
      "context" : "cific wavelength of light, and their diameter is approximately 2–10 nm.(44,82,83) Their structure consists of an inorganic core",
      "startOffset" : 71,
      "endOffset" : 81
    }, {
      "referenceID" : 83,
      "context" : "and shell, which can be modified with biological molecules, such as PEG.(84) Their emission and absorption properties can be controlled precisely by modulating their size and shape.",
      "startOffset" : 72,
      "endOffset" : 76
    }, {
      "referenceID" : 84,
      "context" : "Their emission and absorption properties can be controlled precisely by modulating their size and shape.(85)",
      "startOffset" : 104,
      "endOffset" : 108
    }, {
      "referenceID" : 85,
      "context" : "Because of their high electron and atom density, QDs act as radiosensitizers that absorb high-energy photons and cause localized or targeted damage to tumor cells.(86)",
      "startOffset" : 163,
      "endOffset" : 167
    }, {
      "referenceID" : 2,
      "context" : "Several different “pure” carbon-based constructs have been studied, such as fullerenes and their derivatives, which are composed of carbon atoms arranged in a spherical shape called a truncated icosahedron, and carbon nanotubes (CNTs), which are most frequently studied in biological systems.(3,87) Fullerenes and their derivatives are readily accessible to cells, and are conjugated with various therapeutic molecules because they have a unique nanostructure.",
      "startOffset" : 292,
      "endOffset" : 298
    }, {
      "referenceID" : 86,
      "context" : "Several different “pure” carbon-based constructs have been studied, such as fullerenes and their derivatives, which are composed of carbon atoms arranged in a spherical shape called a truncated icosahedron, and carbon nanotubes (CNTs), which are most frequently studied in biological systems.(3,87) Fullerenes and their derivatives are readily accessible to cells, and are conjugated with various therapeutic molecules because they have a unique nanostructure.",
      "startOffset" : 292,
      "endOffset" : 298
    }, {
      "referenceID" : 39,
      "context" : "Moreover, carbon NMs have been linked with biological molecules and polymers, and so can be effectively used for antitumor applications in vivo.(40) Therefore, functional fullerenes and their derivatives can be linked to a wide variety of active molecules to target tumor cells.",
      "startOffset" : 144,
      "endOffset" : 148
    }, {
      "referenceID" : 86,
      "context" : "Therefore, functional fullerenes and their derivatives can be linked to a wide variety of active molecules to target tumor cells.(87,88) Based on these experiments, fullerenes and their derivatives have become a new class of promising candidates for tumor treatments.",
      "startOffset" : 129,
      "endOffset" : 136
    }, {
      "referenceID" : 87,
      "context" : "Therefore, functional fullerenes and their derivatives can be linked to a wide variety of active molecules to target tumor cells.(87,88) Based on these experiments, fullerenes and their derivatives have become a new class of promising candidates for tumor treatments.",
      "startOffset" : 129,
      "endOffset" : 136
    }, {
      "referenceID" : 88,
      "context" : "The result is not due to toxic effects on tumor cells, but the fullerenes, which have almost no toxicity in vivo or in vitro, have a strong ability to enhance immunity and protect normal tissues from tumor invasion.(89,90) Endohedral metallofullerenes (fullerenes encapsulating a metal atom) have shown dramatic potential for biomedical applications.",
      "startOffset" : 215,
      "endOffset" : 222
    }, {
      "referenceID" : 89,
      "context" : "The result is not due to toxic effects on tumor cells, but the fullerenes, which have almost no toxicity in vivo or in vitro, have a strong ability to enhance immunity and protect normal tissues from tumor invasion.(89,90) Endohedral metallofullerenes (fullerenes encapsulating a metal atom) have shown dramatic potential for biomedical applications.",
      "startOffset" : 215,
      "endOffset" : 222
    }, {
      "referenceID" : 91,
      "context" : "The high antitumor activity may be because the water-soluble NMs can effectively trigger the host immune system to eliminate tumor cells and regulate the angiogenesis and oxidative defense system in vivo.(92)",
      "startOffset" : 204,
      "endOffset" : 208
    }, {
      "referenceID" : 92,
      "context" : "Carbon nanotubes CNTs are coaxial graphite layers with cylinders.(93) CNTs are formed by polymerization of single carbon atoms under specific conditions.",
      "startOffset" : 65,
      "endOffset" : 69
    }, {
      "referenceID" : 93,
      "context" : "CNTs are formed by polymerization of single carbon atoms under specific conditions.(94) According to their structure, CNTs can be divided into two categories: single-walled CNTs (SWCNTs) and multiwalled CNTs (MWCNTs).",
      "startOffset" : 83,
      "endOffset" : 87
    }, {
      "referenceID" : 94,
      "context" : "cylinder nested in other cylinders.(95) With the development of nanotechnology, integration of CNTs into tumor therapeutics is a rapidly advancing field.",
      "startOffset" : 35,
      "endOffset" : 39
    }, {
      "referenceID" : 95,
      "context" : "With the development of nanotechnology, integration of CNTs into tumor therapeutics is a rapidly advancing field.(96,97) There are reports that CNTs promote the phagocytosis of dendritic cells at tumor sites, which produce more antigens to dendritic cells, significantly increasing the immunogenicity of proteins in the tumor.",
      "startOffset" : 113,
      "endOffset" : 120
    }, {
      "referenceID" : 96,
      "context" : "With the development of nanotechnology, integration of CNTs into tumor therapeutics is a rapidly advancing field.(96,97) There are reports that CNTs promote the phagocytosis of dendritic cells at tumor sites, which produce more antigens to dendritic cells, significantly increasing the immunogenicity of proteins in the tumor.",
      "startOffset" : 113,
      "endOffset" : 120
    }, {
      "referenceID" : 97,
      "context" : "There are reports that CNTs promote the phagocytosis of dendritic cells at tumor sites, which produce more antigens to dendritic cells, significantly increasing the immunogenicity of proteins in the tumor.(98) Similarly, inhaled CNTs can inhibit lung-resident dendritic cells and promote lung immune suppression.",
      "startOffset" : 205,
      "endOffset" : 209
    }, {
      "referenceID" : 46,
      "context" : "Similarly, inhaled CNTs can inhibit lung-resident dendritic cells and promote lung immune suppression.(47) Regarding the direct therapeutic effect, CNTs can induce tumor-tissue destruction by PTT, based on strong optical absorbance under NIR-light excitation.",
      "startOffset" : 102,
      "endOffset" : 106
    }, {
      "referenceID" : 98,
      "context" : "Regarding the direct therapeutic effect, CNTs can induce tumor-tissue destruction by PTT, based on strong optical absorbance under NIR-light excitation.(99,100) Therefore, CNTs have attracted interest as efficient PTT agents for tumor treatments.",
      "startOffset" : 152,
      "endOffset" : 160
    }, {
      "referenceID" : 99,
      "context" : "Regarding the direct therapeutic effect, CNTs can induce tumor-tissue destruction by PTT, based on strong optical absorbance under NIR-light excitation.(99,100) Therefore, CNTs have attracted interest as efficient PTT agents for tumor treatments.",
      "startOffset" : 152,
      "endOffset" : 160
    }, {
      "referenceID" : 99,
      "context" : "CNTs are also used as PT tumor-ablation mediators.(100) Due",
      "startOffset" : 50,
      "endOffset" : 55
    }, {
      "referenceID" : 106,
      "context" : "MWCNTs can be stimulated with NIR irradiation to damage cervical tumor HeLa cells(106) and EAC cells.(107)",
      "startOffset" : 101,
      "endOffset" : 106
    }, {
      "referenceID" : 110,
      "context" : "nanomedicine, due to their exceptional physical, chemical, and mechanical properties.(111) Graphene-based NMs have a well-described role in tumor management.",
      "startOffset" : 85,
      "endOffset" : 90
    }, {
      "referenceID" : 111,
      "context" : "Graphene-based NMs have a well-described role in tumor management.(112) Graphene-based NMs are used mainly for PTT.",
      "startOffset" : 66,
      "endOffset" : 71
    }, {
      "referenceID" : 119,
      "context" : "Chitosan nanoparticles Chitosan is a type of cationic oligosaccharide that is the major component of the exoskeleton of crustaceans and insects.(120) Chitosan is a biopolymer containing β-(1,4)2-amino-d-glucose and β-(1,4)-2-acetamido-d-glucose units.",
      "startOffset" : 144,
      "endOffset" : 149
    }, {
      "referenceID" : 72,
      "context" : "Chitosan is a biopolymer containing β-(1,4)2-amino-d-glucose and β-(1,4)-2-acetamido-d-glucose units.(73) Chitosan NPs (ChNPs) are obtained by deacetylation, which removes an acetate moiety from chitin.",
      "startOffset" : 101,
      "endOffset" : 105
    }, {
      "referenceID" : 120,
      "context" : "biocompatibility, biosecurity, biodegradability, and nontoxic characteristics.(121,122) ChNPs are commonly modified with epichlorohydrin and PEG dicarboxylic acid.",
      "startOffset" : 78,
      "endOffset" : 87
    }, {
      "referenceID" : 121,
      "context" : "biocompatibility, biosecurity, biodegradability, and nontoxic characteristics.(121,122) ChNPs are commonly modified with epichlorohydrin and PEG dicarboxylic acid.",
      "startOffset" : 78,
      "endOffset" : 87
    }, {
      "referenceID" : 122,
      "context" : "ChNPs are commonly modified with epichlorohydrin and PEG dicarboxylic acid.(123,124) ChNPs",
      "startOffset" : 75,
      "endOffset" : 84
    }, {
      "referenceID" : 123,
      "context" : "ChNPs are commonly modified with epichlorohydrin and PEG dicarboxylic acid.(123,124) ChNPs",
      "startOffset" : 75,
      "endOffset" : 84
    }, {
      "referenceID" : 124,
      "context" : "of the organism by facilitating the contact between the drug and the tumor-cell membrane.(125,126) Reports show that ChNPs",
      "startOffset" : 89,
      "endOffset" : 98
    }, {
      "referenceID" : 125,
      "context" : "of the organism by facilitating the contact between the drug and the tumor-cell membrane.(125,126) Reports show that ChNPs",
      "startOffset" : 89,
      "endOffset" : 98
    }, {
      "referenceID" : 126,
      "context" : "the humoral immune system, which can be activated at the same time.(127) ChNPs also have a strong immunostimulating",
      "startOffset" : 67,
      "endOffset" : 72
    }, {
      "referenceID" : 127,
      "context" : "effect by increasing the activation and accumulation of polymorphonuclear and macrophage cells, and they induce cytokine production after intravenous injection.(128,129) There is another example that indicates that ChNPs have their own antitumor effects.",
      "startOffset" : 160,
      "endOffset" : 169
    }, {
      "referenceID" : 128,
      "context" : "effect by increasing the activation and accumulation of polymorphonuclear and macrophage cells, and they induce cytokine production after intravenous injection.(128,129) There is another example that indicates that ChNPs have their own antitumor effects.",
      "startOffset" : 160,
      "endOffset" : 169
    }, {
      "referenceID" : 129,
      "context" : "In this way, ChNPs can effectively inhibit proliferation of tumor cells by increasing the concentration of cytostatic agents at the tumor sites.(130) All these attributes and examples show that ChNPs have great potential in tumor therapy.",
      "startOffset" : 144,
      "endOffset" : 149
    }, {
      "referenceID" : 130,
      "context" : "The most pressing problems are potential chronic and acute toxic effects; the potential toxicity of NMs cannot be ignored in antitumor therapy.(131) There have been",
      "startOffset" : 143,
      "endOffset" : 148
    }, {
      "referenceID" : 45,
      "context" : "It has been confirmed that CNTs can damage lung tissue(143) and that they are toxic to the immune system in mice.(46) Besides, the blood incompatibility of CNTs also limits their use in the clinic.",
      "startOffset" : 113,
      "endOffset" : 117
    }, {
      "referenceID" : 145,
      "context" : "The authors believed that it is necessary to research the mechanisms of injury in cells due to NMs extensively before NMs can be used in tumor treatments.(147) Development of tumor therapies is a multidisciplinary field, and with more in-depth research on tumor biology, tumor immunology, molecular biology, and NMs, an ideal therapy or NM will eventually be produced for the treatment",
      "startOffset" : 154,
      "endOffset" : 159
    } ],
    "year" : 2017,
    "abstractText" : "and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). International Journal of Nanomedicine 2017:12 1815–1825 International Journal of Nanomedicine Dovepress",
    "creator" : "Adobe InDesign CS3 (5.0)"
  }
}